Spatz Nora 4

What Happened

• Nora Spatz, Executive Vice President and Chief Accounting Officer of Marathon Bancorp (MBBC), made a series of open-market purchases of company stock from June 3–10, 2026. She acquired a total of 3,819 shares for aggregate cash consideration of approximately $54,797.
• Individual trades: Jun 3 — 722 shares @ $13.75 ($9,926); Jun 4 — 74 shares @ $13.77 ($1,019); Jun 5 — 320 shares @ $14.25 ($4,559); Jun 8 — 197 shares @ $14.24 ($2,805); Jun 9 — 1,904 shares @ $14.50 ($27,608); Jun 10 — 602 shares @ $14.75 ($8,880). These were purchases (code P), which market watchers typically view as a bullish signal, though motivations aren’t stated.

Key Details

• Transaction dates and prices: Jun 3–10, 2026; per-trade prices listed above. Some reported prices are weighted averages reflecting multiple executions (see footnotes).
• Total acquired: 3,819 shares for ~ $54,797.
• Shares owned after the transactions: Not specified in the information provided in this summary (see the filing for post-transaction beneficial ownership).
• Notable footnotes:
  • F1–F4: The reported per-share prices for certain trades are weighted averages; actual executions ranged across the specific price bands (e.g., $13.655–$13.75; $13.75–$14.00; $14.00–$14.25; $14.18–$14.25).
  • F5–F8: Refer to existing holdings that include restricted stock and stock options with stated vesting schedules (20% per year from listed commencement dates).
• Filing timeliness: The Form 4 was filed on 2026-06-11. Because the earliest purchase was on 2026-06-03, that trade appears to have been reported after the typical 2-business-day Form 4 deadline; later trades (e.g., Jun 10) were reported promptly on the 06-11 filing. Check the filing for any tardiness notation or explanations.

Context

• These were straightforward open-market cash purchases (no option exercises, awards, gifts, or sales reported here).
• Purchases by officers can be interpreted as a positive signal by some investors, but they do not prove future performance — motivations are not disclosed.
• For more detail (exact post-transaction holdings, full price breakdowns within the weighted ranges, and any company disclosures), review the actual Form 4 filing (Accession 0001437749-26-020344).